Literature DB >> 21600262

Chromene induces apoptosis via caspase-3 activation in human leukemia HL-60 cells.

Soo-Jin Heo1, Kil-Nam Kim, Weon-Jong Yoon, Chulhong Oh, Young-Ung Choi, Abu Affan, Yeon-Ju Lee, Hyi-Seung Lee, Do-Hyung Kang.   

Abstract

In this study, the potent anti-tumor effects of brown algae on human leukemia HL-60 cells were investigated. The Sargassum siliquastrum extract among the 14 species of brown algae exhibited profound growth inhibitory effect on HL-60 cells in the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, therefore, S. siliquastrum was selected for use in further experiments. The highest inhibitory activity of S. siliquastrum on HL-60 cells was detected in the chloroform fraction, and the active compound was identified as a kind of chromene, sargachromanol E (SE). SE treatment showed significant growth inhibitory effects on HL-60 cells in a dose-dependent manner by inducing apoptosis, as evidenced by the formation of apoptotic bodies, fragmented DNA ladder, and the accumulation of DNA in the sub-G(1) phase of cell cycle. SE induced apoptosis was accompanied by downregulation of Bcl-xL, upregulation of Bax, activation of caspase-3, and cleavage of poly (ADP-ribose) polymerase (PARP). Moreover, z-DEVD-fmk, a caspase-3 inhibitor, significantly inhibited cell cytotoxicity, apoptotic characteristics such as apoptotic bodies, sub-G(1) DNA content, and cleavage of PARP induced by SE. These results suggest that SE exerts its growth inhibitory effects on HL-60 cells through caspase-3-mediated induction of apoptosis. Therefore, SE offers promising chemotherapeuric potential to prevent cancers such as human leukemia. Crown
Copyright © 2011. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21600262     DOI: 10.1016/j.fct.2011.05.011

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  7 in total

1.  Dapson in heterocyclic chemistry, part VIII: synthesis, molecular docking and anticancer activity of some novel sulfonylbiscompounds carrying biologically active 1,3-dihydropyridine, chromene and chromenopyridine moieties.

Authors:  Mansour S Al-Said; Mostafa M Ghorab; Yassin M Nissan
Journal:  Chem Cent J       Date:  2012-07-02       Impact factor: 4.215

2.  Bioactive Cembranoids from the Soft Coral Genus Sinularia sp. in Borneo.

Authors:  Takashi Kamada; Min-Cheol Kang; Chin-Soon Phan; Intan Irna Zanil; You-Jin Jeon; Charles S Vairappan
Journal:  Mar Drugs       Date:  2018-03-21       Impact factor: 5.118

Review 3.  From Marine Origin to Therapeutics: The Antitumor Potential of Marine Algae-Derived Compounds.

Authors:  Celso Alves; Joana Silva; Susete Pinteus; Helena Gaspar; Maria C Alpoim; Luis M Botana; Rui Pedrosa
Journal:  Front Pharmacol       Date:  2018-08-06       Impact factor: 5.810

Review 4.  Natural 6-hydroxy-chromanols and -chromenols: structural diversity, biosynthetic pathways and health implications.

Authors:  Marc Birringer; Karsten Siems; Alexander Maxones; Jan Frank; Stefan Lorkowski
Journal:  RSC Adv       Date:  2018-01-26       Impact factor: 4.036

5.  Algae extracts and methyl jasmonate anti-cancer activities in prostate cancer: choreographers of 'the dance macabre'.

Authors:  Ammad Ahmad Farooqi; Ghazala Butt; Zubia Razzaq
Journal:  Cancer Cell Int       Date:  2012-11-26       Impact factor: 5.722

6.  An Aqueous Extract of Marine Microalgae Exhibits Antimetastatic Activity through Preferential Killing of Suspended Cancer Cells and Anticolony Forming Activity.

Authors:  Syam Prakash Somasekharan; Amal El-Naggar; Poul H Sorensen; Yuzhuo Wang; Hongwei Cheng
Journal:  Evid Based Complement Alternat Med       Date:  2016-08-31       Impact factor: 2.629

7.  Anticancer Activities of Meroterpenoids Isolated from the Brown Alga Cystoseira usneoides against the Human Colon Cancer Cells HT-29.

Authors:  Hanaa Zbakh; Eva Zubía; Carolina De Los Reyes; José M Calderón-Montaño; Virginia Motilva
Journal:  Foods       Date:  2020-03-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.